NSite Medical put an FDA-cleared, radiation-free spine scanner where a scanner has never been - the camera already in your pocket.
The MyBackHub wordmark. A gradient that leans, like a spine caught mid-lean - which, if you have ever waited in an imaging center hallway, is a small and pointed joke.
Back pain is enormous, expensive, and weirdly badly served. The care exists - imaging here, physical therapy there, a surgeon down the hall, a pain clinic across town - but the pieces almost never talk to each other. MyBackHub's founding idea is that the pieces should live in one place, and that the first piece, the scan, should not require you to leave the house or absorb any radiation.
The company behind it is Nsite, Inc., which has worn several names on its way here: NSite Medical, the National Scoliosis Clinic, The Scoliosis Solution, and now MyBackHub. That is a lot of letterhead for a startup with roughly a dozen people, and there is a logic to it. You earn trust in a narrow, genuinely hard condition - adolescent scoliosis, the kind that means repeat X-rays and anxious parents - and then, once the technology works, you point it at the far larger and far messier market of ordinary back pain.
The narrow, hard part came first. Around 2019 and 2020, Michael J. Gardner - a professor of orthopedic surgery at Stanford - and colleagues built a virtual, scoliosis-specific physical therapy program for patients who could not easily get specialist care. Early results reported about a 31% reduction in pain after three months. That is the sort of number that either sits in a slide deck forever or makes a founder ask an uncomfortable follow-up question: if this works for scoliosis, why are we only doing scoliosis?
"Our mobile app leverages cutting-edge AI to democratize care, putting it directly into the hands of anyone with a smartphone."
Kevon Saber, Head of Business Development, NSite MedicalThe technical bet is the part worth slowing down for. Scoliosis screening traditionally means a scoliometer in a clinic or, more consequentially, X-rays - and X-rays, repeated over the years of a child's growth, are exactly the thing patients and parents would rather avoid. NSite's insight was that the hardware to measure a spine was already mass-produced and sitting in millions of pockets: the camera and LiDAR depth sensor in a modern smartphone. The hard part was never the lens. It was teaching software to reliably see a spine, quantify a curve, and do it well enough that the FDA would agree.
In December 2023, it did. NSite Medical received FDA 510(k) clearance for an AI-based scoliosis scanning app that evaluates the presence, absence, and severity of spinal curvature without ionizing radiation. A peer-reviewed study has since reported that mobile-device 3D scanning outperformed the traditional scoliometer in assessing adolescent idiopathic scoliosis. Clearance is the moment a clever demo becomes a regulated medical product, which is a different and much harder thing to be.
The consumer experience compresses the usual months-long path to a first spine consult into a few phone minutes, then keeps going. Membership is available at little to no cost through select Medicare and insurance plans.
The PostureBackNeck Assessment reads your posture, movement, and spinal alignment from home - radiation-free.
AI turns the scan into a personalized recovery plan built around your specific imbalances and stress points.
Adaptive exercises, live Pilates classes, licensed physical therapists, and Stanford's Empowered Relief pain program.
Daily check-ins, progress analytics, and a 24/7 AI companion that adjusts as you improve.
Clinical-grade AI scan completed at home in about 15 minutes, identifying spinal imbalances and stress points.
Consumer / 2025FDA 510(k)-cleared tool that screens, quantifies, and monitors spinal curvature using AI and 3D/LiDAR - no radiation.
FDA cleared / 2023Virtual, scoliosis-specific physical therapy program - the origin product - with ~31% pain reduction reported at three months.
Launched / 2020Personalized digital coaching with adaptive exercises that evolve as you get stronger.
Consumer / 2025Stanford-developed ~80-minute pain program with evidence comparable to eight CBT sessions.
Licensed / 2025Live Pilates instructors, licensed PTs, a 24/7 AI back-health companion, and a moderated community marketplace.
Consumer / 2025The pricing tells you what the company is optimizing for. A one-time $29 assessment is roughly the price of a co-pay. Membership can drop to essentially nothing for patients whose Medicare or insurance plans cover it. The standalone Scoliosis Solution program runs about $199 for six weeks.
The cheapest useful intervention in medicine is often the one nobody gets paid to deliver. Building the business around reimbursed, low-friction access is a bet that scale - lots of backs, coordinated care - beats margin per patient.
Prices per the company's public site; may change. Treat as indicative.
Relative cost to the patient. Bars scaled for illustration; membership is little-to-no cost through eligible plans.
Professor of orthopedic surgery at Stanford University School of Medicine. Not a career founder - a practicing surgeon who built the scoliosis program that became the company.
Co-founder and inventor credited on the FDA-cleared scanning technology.
"This will have an immediate impact on scoliosis management pathways for patients, pediatricians, orthopedic surgeons and physical therapists."
Michael J. Gardner, MD - on FDA clearance, December 2023Nsite, Inc. is established in Menlo Park to bring AI and telehealth to scoliosis screening and care.
A virtual, scoliosis-specific physical therapy program for underserved patients - early results show ~31% pain reduction at three months.
NSite earns FDA 510(k) clearance for its radiation-free, AI-based scoliosis scanning app.
The company expands beyond scoliosis, launching a consumer back-health platform with AI assessment, experts, and community.
NSite Medical has raised venture funding from investors including StartX (the Stanford-affiliated accelerator), cultivate(MD), Genesis Innovation Group, and Octane. Public trackers disagree on the total - figures range from roughly $2.7M to $3.7M reported, with at least one aggregator listing a much larger $30M.
Funding figures vary widely across public databases and are unverified by the company here. Treat totals as approximate.
"Our mobile app leverages cutting-edge AI to democratize care, putting it directly into the hands of anyone with a smartphone."
Kevon Saber - Head of Business Development"Achieving FDA clearance is a testament to the hard work and innovative spirit of our team."
Malcolm DeBaun, MD - Co-Founder & Inventor"Achieving FDA approval allows our company to bring this novel AI-based software to patients and providers enabling early identification."
Steve Avila, MBA - Director of Operations